http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Mon, 15 Jun 2026 16:11:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++PURE+BIOSCIENCE%2C+INC.+++++For%3A+Apr+30/26647446.html si-local-file:///var/storage/secattach/20260615/26647446.html http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++PURE+BIOSCIENCE%2C+INC.+++++For%3A+Apr+30/26647446.html Mon, 15 Jun 2026 16:11:00 -0400 O.00183576 PURE http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++PURE+BIOSCIENCE%2C+INC.+++++For%3A+Apr+30/26647446.html si-local-file:///var/storage/secattach/20260615/26647446.html http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++PURE+BIOSCIENCE%2C+INC.+++++For%3A+Apr+30/26647446.html Mon, 15 Jun 2026 16:11:00 -0400 O.00183576 PURE http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++PURE+BIOSCIENCE%2C+INC.+++++For%3A+Jun+15/26647307.html si-local-file:///var/storage/secattach/20260615/26647307.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++PURE+BIOSCIENCE%2C+INC.+++++For%3A+Jun+15/26647307.html Mon, 15 Jun 2026 16:06:00 -0400 O.00183576 PURE http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++PURE+BIOSCIENCE%2C+INC.+++++For%3A+Jun+15/26647307.html si-local-file:///var/storage/secattach/20260615/26647307.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++PURE+BIOSCIENCE%2C+INC.+++++For%3A+Jun+15/26647307.html Mon, 15 Jun 2026 16:06:00 -0400 O.00183576 PURE http://www.streetinsider.com/Press+Releases/PURE+Bioscience+Reports+Fiscal+Third+Quarter+2026+Financial+Results/26647254.html <p> EL CAJON, Calif.--(BUSINESS WIRE)-- PURE Bioscience, Inc. (<a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.otcmarkets.com%2Fstock%2FPURE%2Fquote&amp;esheet=54554452&amp;newsitemid=20260615772156&amp;lan=en-US&amp;anchor=OTCQB%3A+PURE&amp;index=1&amp;md5=2aeceaa952d22a9e845df6282cc6e053" shape="rect">OTCQB: PURE</a>) (“PURE,” the “Company” or “we”), creator of the patented non-toxic silver dihydrogen citrate (<a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fpurebio.com%2Ftechnology%2F&amp;esheet=54554452&amp;newsitemid=20260615772156&amp;lan=en-US&amp;anchor=SDC&amp;index=2&amp;md5=fae341981299162c6ce1f1333d807e39" shape="rect">SDC</a>) antimicrobial, today reported financial results for the fiscal third quarter ended April 30, 2026. </p><p> <b>Summary of Results of Operations – Third Quarter</b> </p><ul class="bwlistdisc"> <li> Net product sales were $506,000 and $489,000 for the fiscal third quarters ended April 30, 2026 and 2025, respectively. The $17,000 increase was attributable to higher sales across our distribution network. </li> <li> Net loss for the fiscal third quarter ended April 30, 2026 was $624,000, compared to http://www.streetinsider.com/Press+Releases/PURE+Bioscience+Reports+Fiscal+Third+Quarter+2026+Financial+Results/26647254.html Mon, 15 Jun 2026 16:05:00 -0400 O.00183576 PURE http://www.streetinsider.com/Press+Releases/PURE+Bioscience+Reports+Fiscal+Third+Quarter+2026+Financial+Results/26647254.html <p> EL CAJON, Calif.--(BUSINESS WIRE)-- PURE Bioscience, Inc. (<a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.otcmarkets.com%2Fstock%2FPURE%2Fquote&amp;esheet=54554452&amp;newsitemid=20260615772156&amp;lan=en-US&amp;anchor=OTCQB%3A+PURE&amp;index=1&amp;md5=2aeceaa952d22a9e845df6282cc6e053" shape="rect">OTCQB: PURE</a>) (“PURE,” the “Company” or “we”), creator of the patented non-toxic silver dihydrogen citrate (<a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fpurebio.com%2Ftechnology%2F&amp;esheet=54554452&amp;newsitemid=20260615772156&amp;lan=en-US&amp;anchor=SDC&amp;index=2&amp;md5=fae341981299162c6ce1f1333d807e39" shape="rect">SDC</a>) antimicrobial, today reported financial results for the fiscal third quarter ended April 30, 2026. </p><p> <b>Summary of Results of Operations – Third Quarter</b> </p><ul class="bwlistdisc"> <li> Net product sales were $506,000 and $489,000 for the fiscal third quarters ended April 30, 2026 and 2025, respectively. The $17,000 increase was attributable to higher sales across our distribution network. </li> <li> Net loss for the fiscal third quarter ended April 30, 2026 was $624,000, compared to http://www.streetinsider.com/Press+Releases/PURE+Bioscience+Reports+Fiscal+Third+Quarter+2026+Financial+Results/26647254.html Mon, 15 Jun 2026 16:05:00 -0400 O.00183576 PURE http://www.streetinsider.com/Business+Wire/PURE+Bioscience+Reports+Fiscal+Third+Quarter+2026+Financial+Results/26647254.html <p> EL CAJON, Calif.--(BUSINESS WIRE)-- PURE Bioscience, Inc. (<a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.otcmarkets.com%2Fstock%2FPURE%2Fquote&amp;esheet=54554452&amp;newsitemid=20260615772156&amp;lan=en-US&amp;anchor=OTCQB%3A+PURE&amp;index=1&amp;md5=2aeceaa952d22a9e845df6282cc6e053" shape="rect">OTCQB: PURE</a>) (“PURE,” the “Company” or “we”), creator of the patented non-toxic silver dihydrogen citrate (<a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fpurebio.com%2Ftechnology%2F&amp;esheet=54554452&amp;newsitemid=20260615772156&amp;lan=en-US&amp;anchor=SDC&amp;index=2&amp;md5=fae341981299162c6ce1f1333d807e39" shape="rect">SDC</a>) antimicrobial, today reported financial results for the fiscal third quarter ended April 30, 2026. </p><p> <b>Summary of Results of Operations – Third Quarter</b> </p><ul class="bwlistdisc"> <li> Net product sales were $506,000 and $489,000 for the fiscal third quarters ended April 30, 2026 and 2025, respectively. The $17,000 increase was attributable to higher sales across our distribution network. </li> <li> Net loss for the fiscal third quarter ended April 30, 2026 was $624,000, compared to http://www.streetinsider.com/Business+Wire/PURE+Bioscience+Reports+Fiscal+Third+Quarter+2026+Financial+Results/26647254.html Mon, 15 Jun 2026 16:05:00 -0400 O.00183576 PURE http://www.streetinsider.com/Business+Wire/PURE+Bioscience+Reports+Fiscal+Third+Quarter+2026+Financial+Results/26647254.html <p> EL CAJON, Calif.--(BUSINESS WIRE)-- PURE Bioscience, Inc. (<a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.otcmarkets.com%2Fstock%2FPURE%2Fquote&amp;esheet=54554452&amp;newsitemid=20260615772156&amp;lan=en-US&amp;anchor=OTCQB%3A+PURE&amp;index=1&amp;md5=2aeceaa952d22a9e845df6282cc6e053" shape="rect">OTCQB: PURE</a>) (“PURE,” the “Company” or “we”), creator of the patented non-toxic silver dihydrogen citrate (<a target="_blank" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fpurebio.com%2Ftechnology%2F&amp;esheet=54554452&amp;newsitemid=20260615772156&amp;lan=en-US&amp;anchor=SDC&amp;index=2&amp;md5=fae341981299162c6ce1f1333d807e39" shape="rect">SDC</a>) antimicrobial, today reported financial results for the fiscal third quarter ended April 30, 2026. </p><p> <b>Summary of Results of Operations – Third Quarter</b> </p><ul class="bwlistdisc"> <li> Net product sales were $506,000 and $489,000 for the fiscal third quarters ended April 30, 2026 and 2025, respectively. The $17,000 increase was attributable to higher sales across our distribution network. </li> <li> Net loss for the fiscal third quarter ended April 30, 2026 was $624,000, compared to http://www.streetinsider.com/Business+Wire/PURE+Bioscience+Reports+Fiscal+Third+Quarter+2026+Financial+Results/26647254.html Mon, 15 Jun 2026 16:05:00 -0400 O.00183576 PURE http://www.streetinsider.com/Press+Releases/Purecore+Strengthens+Technical+Advisory+Expertise+with+Nuclear+Fuel+Cycle+and+Uranium+Enrichment+Specialist%2C+Ted+Rygas%2C+PhD/26645258.html <p align="justify">VANCOUVER, British Columbia, June 15, 2026 (GLOBE NEWSWIRE) -- <strong>Purecore Metals Inc. (CSE: PURE) (FSE: J8Y) (“Purecore” or the “Company”)</strong> is pleased to announce the addition of Dr. Ted Rygas as Technical Advisor, bringing extensive experience in uranium isotope enrichment, nuclear fuel-cycle technologies, separation science, chemical engineering, and advanced process development.</p> <p><strong>Dr. Rygas’ technical background includes:</strong></p> <ul type="disc"><li style="margin-bottom:4pt; text-align:justify;">Over 30 years of experience in separation science, isotope separation, process development, and pilot-plant operations</li><li style="margin-bottom:4pt; text-align:justify;">Former Research Engineer with Cameco Corporation, contributing to the CRISLA laser-based uranium isotope enrichment project</li><li style="margin-bottom:4pt; text-align:justify;">Independent consultant since 2017, http://www.streetinsider.com/Press+Releases/Purecore+Strengthens+Technical+Advisory+Expertise+with+Nuclear+Fuel+Cycle+and+Uranium+Enrichment+Specialist%2C+Ted+Rygas%2C+PhD/26645258.html Mon, 15 Jun 2026 09:30:00 -0400 A.04592075 A.04618790 A.08119513 J8Y O.00786429 O.01104272 O.02567468 PURE http://www.streetinsider.com/Press+Releases/Purecore+Strengthens+Technical+Advisory+Expertise+with+Nuclear+Fuel+Cycle+and+Uranium+Enrichment+Specialist%2C+Ted+Rygas%2C+PhD/26645258.html <p align="justify">VANCOUVER, British Columbia, June 15, 2026 (GLOBE NEWSWIRE) -- <strong>Purecore Metals Inc. (CSE: PURE) (FSE: J8Y) (“Purecore” or the “Company”)</strong> is pleased to announce the addition of Dr. Ted Rygas as Technical Advisor, bringing extensive experience in uranium isotope enrichment, nuclear fuel-cycle technologies, separation science, chemical engineering, and advanced process development.</p> <p><strong>Dr. Rygas’ technical background includes:</strong></p> <ul type="disc"><li style="margin-bottom:4pt; text-align:justify;">Over 30 years of experience in separation science, isotope separation, process development, and pilot-plant operations</li><li style="margin-bottom:4pt; text-align:justify;">Former Research Engineer with Cameco Corporation, contributing to the CRISLA laser-based uranium isotope enrichment project</li><li style="margin-bottom:4pt; text-align:justify;">Independent consultant since 2017, http://www.streetinsider.com/Press+Releases/Purecore+Strengthens+Technical+Advisory+Expertise+with+Nuclear+Fuel+Cycle+and+Uranium+Enrichment+Specialist%2C+Ted+Rygas%2C+PhD/26645258.html Mon, 15 Jun 2026 09:30:00 -0400 A.04592075 A.04618790 A.08119513 J8Y O.00786429 O.01104272 O.02567468 PURE http://www.streetinsider.com/Press+Releases/Purecore+Strengthens+Technical+Advisory+Expertise+with+Nuclear+Fuel+Cycle+and+Uranium+Enrichment+Specialist%2C+Ted+Rygas%2C+PhD/26645258.html <p align="justify">VANCOUVER, British Columbia, June 15, 2026 (GLOBE NEWSWIRE) -- <strong>Purecore Metals Inc. (CSE: PURE) (FSE: J8Y) (“Purecore” or the “Company”)</strong> is pleased to announce the addition of Dr. Ted Rygas as Technical Advisor, bringing extensive experience in uranium isotope enrichment, nuclear fuel-cycle technologies, separation science, chemical engineering, and advanced process development.</p> <p><strong>Dr. Rygas’ technical background includes:</strong></p> <ul type="disc"><li style="margin-bottom:4pt; text-align:justify;">Over 30 years of experience in separation science, isotope separation, process development, and pilot-plant operations</li><li style="margin-bottom:4pt; text-align:justify;">Former Research Engineer with Cameco Corporation, contributing to the CRISLA laser-based uranium isotope enrichment project</li><li style="margin-bottom:4pt; text-align:justify;">Independent consultant since 2017, http://www.streetinsider.com/Press+Releases/Purecore+Strengthens+Technical+Advisory+Expertise+with+Nuclear+Fuel+Cycle+and+Uranium+Enrichment+Specialist%2C+Ted+Rygas%2C+PhD/26645258.html Mon, 15 Jun 2026 09:30:00 -0400 A.04592075 A.04618790 A.08119513 J8Y O.00786429 O.01104272 O.02567468 PURE http://www.streetinsider.com/Press+Releases/Purecore+Strengthens+Technical+Advisory+Expertise+with+Nuclear+Fuel+Cycle+and+Uranium+Enrichment+Specialist%2C+Ted+Rygas%2C+PhD/26645258.html <p align="justify">VANCOUVER, British Columbia, June 15, 2026 (GLOBE NEWSWIRE) -- <strong>Purecore Metals Inc. (CSE: PURE) (FSE: J8Y) (“Purecore” or the “Company”)</strong> is pleased to announce the addition of Dr. Ted Rygas as Technical Advisor, bringing extensive experience in uranium isotope enrichment, nuclear fuel-cycle technologies, separation science, chemical engineering, and advanced process development.</p> <p><strong>Dr. Rygas’ technical background includes:</strong></p> <ul type="disc"><li style="margin-bottom:4pt; text-align:justify;">Over 30 years of experience in separation science, isotope separation, process development, and pilot-plant operations</li><li style="margin-bottom:4pt; text-align:justify;">Former Research Engineer with Cameco Corporation, contributing to the CRISLA laser-based uranium isotope enrichment project</li><li style="margin-bottom:4pt; text-align:justify;">Independent consultant since 2017, http://www.streetinsider.com/Press+Releases/Purecore+Strengthens+Technical+Advisory+Expertise+with+Nuclear+Fuel+Cycle+and+Uranium+Enrichment+Specialist%2C+Ted+Rygas%2C+PhD/26645258.html Mon, 15 Jun 2026 09:30:00 -0400 A.04592075 A.04618790 A.08119513 J8Y O.00786429 O.01104272 O.02567468 PURE http://www.streetinsider.com/Press+Releases/Purecore+Strengthens+Technical+Advisory+Expertise+with+Nuclear+Fuel+Cycle+and+Uranium+Enrichment+Specialist%2C+Ted+Rygas%2C+PhD/26645258.html <p align="justify">VANCOUVER, British Columbia, June 15, 2026 (GLOBE NEWSWIRE) -- <strong>Purecore Metals Inc. (CSE: PURE) (FSE: J8Y) (“Purecore” or the “Company”)</strong> is pleased to announce the addition of Dr. Ted Rygas as Technical Advisor, bringing extensive experience in uranium isotope enrichment, nuclear fuel-cycle technologies, separation science, chemical engineering, and advanced process development.</p> <p><strong>Dr. Rygas’ technical background includes:</strong></p> <ul type="disc"><li style="margin-bottom:4pt; text-align:justify;">Over 30 years of experience in separation science, isotope separation, process development, and pilot-plant operations</li><li style="margin-bottom:4pt; text-align:justify;">Former Research Engineer with Cameco Corporation, contributing to the CRISLA laser-based uranium isotope enrichment project</li><li style="margin-bottom:4pt; text-align:justify;">Independent consultant since 2017, http://www.streetinsider.com/Press+Releases/Purecore+Strengthens+Technical+Advisory+Expertise+with+Nuclear+Fuel+Cycle+and+Uranium+Enrichment+Specialist%2C+Ted+Rygas%2C+PhD/26645258.html Mon, 15 Jun 2026 09:30:00 -0400 A.04592075 A.04618790 A.08119513 J8Y O.00786429 O.01104272 O.02567468 PURE http://www.streetinsider.com/Press+Releases/Purecore+Strengthens+Technical+Advisory+Expertise+with+Nuclear+Fuel+Cycle+and+Uranium+Enrichment+Specialist%2C+Ted+Rygas%2C+PhD/26645258.html <p align="justify">VANCOUVER, British Columbia, June 15, 2026 (GLOBE NEWSWIRE) -- <strong>Purecore Metals Inc. (CSE: PURE) (FSE: J8Y) (“Purecore” or the “Company”)</strong> is pleased to announce the addition of Dr. Ted Rygas as Technical Advisor, bringing extensive experience in uranium isotope enrichment, nuclear fuel-cycle technologies, separation science, chemical engineering, and advanced process development.</p> <p><strong>Dr. Rygas’ technical background includes:</strong></p> <ul type="disc"><li style="margin-bottom:4pt; text-align:justify;">Over 30 years of experience in separation science, isotope separation, process development, and pilot-plant operations</li><li style="margin-bottom:4pt; text-align:justify;">Former Research Engineer with Cameco Corporation, contributing to the CRISLA laser-based uranium isotope enrichment project</li><li style="margin-bottom:4pt; text-align:justify;">Independent consultant since 2017, http://www.streetinsider.com/Press+Releases/Purecore+Strengthens+Technical+Advisory+Expertise+with+Nuclear+Fuel+Cycle+and+Uranium+Enrichment+Specialist%2C+Ted+Rygas%2C+PhD/26645258.html Mon, 15 Jun 2026 09:30:00 -0400 A.04592075 A.04618790 A.08119513 J8Y O.00786429 O.01104272 O.02567468 PURE http://www.streetinsider.com/Press+Releases/Purecore+Strengthens+Technical+Advisory+Expertise+with+Nuclear+Fuel+Cycle+and+Uranium+Enrichment+Specialist%2C+Ted+Rygas%2C+PhD/26645258.html <p align="justify">VANCOUVER, British Columbia, June 15, 2026 (GLOBE NEWSWIRE) -- <strong>Purecore Metals Inc. (CSE: PURE) (FSE: J8Y) (“Purecore” or the “Company”)</strong> is pleased to announce the addition of Dr. Ted Rygas as Technical Advisor, bringing extensive experience in uranium isotope enrichment, nuclear fuel-cycle technologies, separation science, chemical engineering, and advanced process development.</p> <p><strong>Dr. Rygas’ technical background includes:</strong></p> <ul type="disc"><li style="margin-bottom:4pt; text-align:justify;">Over 30 years of experience in separation science, isotope separation, process development, and pilot-plant operations</li><li style="margin-bottom:4pt; text-align:justify;">Former Research Engineer with Cameco Corporation, contributing to the CRISLA laser-based uranium isotope enrichment project</li><li style="margin-bottom:4pt; text-align:justify;">Independent consultant since 2017, http://www.streetinsider.com/Press+Releases/Purecore+Strengthens+Technical+Advisory+Expertise+with+Nuclear+Fuel+Cycle+and+Uranium+Enrichment+Specialist%2C+Ted+Rygas%2C+PhD/26645258.html Mon, 15 Jun 2026 09:30:00 -0400 A.04592075 A.04618790 A.08119513 J8Y O.00786429 O.01104272 O.02567468 PURE http://www.streetinsider.com/Press+Releases/Purecore+Strengthens+Technical+Advisory+Expertise+with+Nuclear+Fuel+Cycle+and+Uranium+Enrichment+Specialist%2C+Ted+Rygas%2C+PhD/26645258.html <p align="justify">VANCOUVER, British Columbia, June 15, 2026 (GLOBE NEWSWIRE) -- <strong>Purecore Metals Inc. (CSE: PURE) (FSE: J8Y) (“Purecore” or the “Company”)</strong> is pleased to announce the addition of Dr. Ted Rygas as Technical Advisor, bringing extensive experience in uranium isotope enrichment, nuclear fuel-cycle technologies, separation science, chemical engineering, and advanced process development.</p> <p><strong>Dr. Rygas’ technical background includes:</strong></p> <ul type="disc"><li style="margin-bottom:4pt; text-align:justify;">Over 30 years of experience in separation science, isotope separation, process development, and pilot-plant operations</li><li style="margin-bottom:4pt; text-align:justify;">Former Research Engineer with Cameco Corporation, contributing to the CRISLA laser-based uranium isotope enrichment project</li><li style="margin-bottom:4pt; text-align:justify;">Independent consultant since 2017, http://www.streetinsider.com/Press+Releases/Purecore+Strengthens+Technical+Advisory+Expertise+with+Nuclear+Fuel+Cycle+and+Uranium+Enrichment+Specialist%2C+Ted+Rygas%2C+PhD/26645258.html Mon, 15 Jun 2026 09:30:00 -0400 A.04592075 A.04618790 A.08119513 J8Y O.00786429 O.01104272 O.02567468 PURE http://www.streetinsider.com/Globe+Newswire/Purecore+Strengthens+Technical+Advisory+Expertise+with+Nuclear+Fuel+Cycle+and+Uranium+Enrichment+Specialist%2C+Ted+Rygas%2C+PhD/26645258.html <p align="justify">VANCOUVER, British Columbia, June 15, 2026 (GLOBE NEWSWIRE) -- <strong>Purecore Metals Inc. (CSE: PURE) (FSE: J8Y) (“Purecore” or the “Company”)</strong> is pleased to announce the addition of Dr. Ted Rygas as Technical Advisor, bringing extensive experience in uranium isotope enrichment, nuclear fuel-cycle technologies, separation science, chemical engineering, and advanced process development.</p> <p><strong>Dr. Rygas’ technical background includes:</strong></p> <ul type="disc"><li style="margin-bottom:4pt; text-align:justify;">Over 30 years of experience in separation science, isotope separation, process development, and pilot-plant operations</li><li style="margin-bottom:4pt; text-align:justify;">Former Research Engineer with Cameco Corporation, contributing to the CRISLA laser-based uranium isotope enrichment project</li><li style="margin-bottom:4pt; text-align:justify;">Independent consultant since 2017, http://www.streetinsider.com/Globe+Newswire/Purecore+Strengthens+Technical+Advisory+Expertise+with+Nuclear+Fuel+Cycle+and+Uranium+Enrichment+Specialist%2C+Ted+Rygas%2C+PhD/26645258.html Mon, 15 Jun 2026 09:30:00 -0400 A.04592075 A.04618790 A.08119513 J8Y O.00786429 O.01104272 O.02567468 PURE http://www.streetinsider.com/Globe+Newswire/Purecore+Strengthens+Technical+Advisory+Expertise+with+Nuclear+Fuel+Cycle+and+Uranium+Enrichment+Specialist%2C+Ted+Rygas%2C+PhD/26645258.html <p align="justify">VANCOUVER, British Columbia, June 15, 2026 (GLOBE NEWSWIRE) -- <strong>Purecore Metals Inc. (CSE: PURE) (FSE: J8Y) (“Purecore” or the “Company”)</strong> is pleased to announce the addition of Dr. Ted Rygas as Technical Advisor, bringing extensive experience in uranium isotope enrichment, nuclear fuel-cycle technologies, separation science, chemical engineering, and advanced process development.</p> <p><strong>Dr. Rygas’ technical background includes:</strong></p> <ul type="disc"><li style="margin-bottom:4pt; text-align:justify;">Over 30 years of experience in separation science, isotope separation, process development, and pilot-plant operations</li><li style="margin-bottom:4pt; text-align:justify;">Former Research Engineer with Cameco Corporation, contributing to the CRISLA laser-based uranium isotope enrichment project</li><li style="margin-bottom:4pt; text-align:justify;">Independent consultant since 2017, http://www.streetinsider.com/Globe+Newswire/Purecore+Strengthens+Technical+Advisory+Expertise+with+Nuclear+Fuel+Cycle+and+Uranium+Enrichment+Specialist%2C+Ted+Rygas%2C+PhD/26645258.html Mon, 15 Jun 2026 09:30:00 -0400 A.04592075 A.04618790 A.08119513 J8Y O.00786429 O.01104272 O.02567468 PURE http://www.streetinsider.com/Globe+Newswire/Purecore+Strengthens+Technical+Advisory+Expertise+with+Nuclear+Fuel+Cycle+and+Uranium+Enrichment+Specialist%2C+Ted+Rygas%2C+PhD/26645258.html <p align="justify">VANCOUVER, British Columbia, June 15, 2026 (GLOBE NEWSWIRE) -- <strong>Purecore Metals Inc. (CSE: PURE) (FSE: J8Y) (“Purecore” or the “Company”)</strong> is pleased to announce the addition of Dr. Ted Rygas as Technical Advisor, bringing extensive experience in uranium isotope enrichment, nuclear fuel-cycle technologies, separation science, chemical engineering, and advanced process development.</p> <p><strong>Dr. Rygas’ technical background includes:</strong></p> <ul type="disc"><li style="margin-bottom:4pt; text-align:justify;">Over 30 years of experience in separation science, isotope separation, process development, and pilot-plant operations</li><li style="margin-bottom:4pt; text-align:justify;">Former Research Engineer with Cameco Corporation, contributing to the CRISLA laser-based uranium isotope enrichment project</li><li style="margin-bottom:4pt; text-align:justify;">Independent consultant since 2017, http://www.streetinsider.com/Globe+Newswire/Purecore+Strengthens+Technical+Advisory+Expertise+with+Nuclear+Fuel+Cycle+and+Uranium+Enrichment+Specialist%2C+Ted+Rygas%2C+PhD/26645258.html Mon, 15 Jun 2026 09:30:00 -0400 A.04592075 A.04618790 A.08119513 J8Y O.00786429 O.01104272 O.02567468 PURE http://www.streetinsider.com/Globe+Newswire/Purecore+Strengthens+Technical+Advisory+Expertise+with+Nuclear+Fuel+Cycle+and+Uranium+Enrichment+Specialist%2C+Ted+Rygas%2C+PhD/26645258.html <p align="justify">VANCOUVER, British Columbia, June 15, 2026 (GLOBE NEWSWIRE) -- <strong>Purecore Metals Inc. (CSE: PURE) (FSE: J8Y) (“Purecore” or the “Company”)</strong> is pleased to announce the addition of Dr. Ted Rygas as Technical Advisor, bringing extensive experience in uranium isotope enrichment, nuclear fuel-cycle technologies, separation science, chemical engineering, and advanced process development.</p> <p><strong>Dr. Rygas’ technical background includes:</strong></p> <ul type="disc"><li style="margin-bottom:4pt; text-align:justify;">Over 30 years of experience in separation science, isotope separation, process development, and pilot-plant operations</li><li style="margin-bottom:4pt; text-align:justify;">Former Research Engineer with Cameco Corporation, contributing to the CRISLA laser-based uranium isotope enrichment project</li><li style="margin-bottom:4pt; text-align:justify;">Independent consultant since 2017, http://www.streetinsider.com/Globe+Newswire/Purecore+Strengthens+Technical+Advisory+Expertise+with+Nuclear+Fuel+Cycle+and+Uranium+Enrichment+Specialist%2C+Ted+Rygas%2C+PhD/26645258.html Mon, 15 Jun 2026 09:30:00 -0400 A.04592075 A.04618790 A.08119513 J8Y O.00786429 O.01104272 O.02567468 PURE http://www.streetinsider.com/Globe+Newswire/Purecore+Strengthens+Technical+Advisory+Expertise+with+Nuclear+Fuel+Cycle+and+Uranium+Enrichment+Specialist%2C+Ted+Rygas%2C+PhD/26645258.html <p align="justify">VANCOUVER, British Columbia, June 15, 2026 (GLOBE NEWSWIRE) -- <strong>Purecore Metals Inc. (CSE: PURE) (FSE: J8Y) (“Purecore” or the “Company”)</strong> is pleased to announce the addition of Dr. Ted Rygas as Technical Advisor, bringing extensive experience in uranium isotope enrichment, nuclear fuel-cycle technologies, separation science, chemical engineering, and advanced process development.</p> <p><strong>Dr. Rygas’ technical background includes:</strong></p> <ul type="disc"><li style="margin-bottom:4pt; text-align:justify;">Over 30 years of experience in separation science, isotope separation, process development, and pilot-plant operations</li><li style="margin-bottom:4pt; text-align:justify;">Former Research Engineer with Cameco Corporation, contributing to the CRISLA laser-based uranium isotope enrichment project</li><li style="margin-bottom:4pt; text-align:justify;">Independent consultant since 2017, http://www.streetinsider.com/Globe+Newswire/Purecore+Strengthens+Technical+Advisory+Expertise+with+Nuclear+Fuel+Cycle+and+Uranium+Enrichment+Specialist%2C+Ted+Rygas%2C+PhD/26645258.html Mon, 15 Jun 2026 09:30:00 -0400 A.04592075 A.04618790 A.08119513 J8Y O.00786429 O.01104272 O.02567468 PURE http://www.streetinsider.com/Globe+Newswire/Purecore+Strengthens+Technical+Advisory+Expertise+with+Nuclear+Fuel+Cycle+and+Uranium+Enrichment+Specialist%2C+Ted+Rygas%2C+PhD/26645258.html <p align="justify">VANCOUVER, British Columbia, June 15, 2026 (GLOBE NEWSWIRE) -- <strong>Purecore Metals Inc. (CSE: PURE) (FSE: J8Y) (“Purecore” or the “Company”)</strong> is pleased to announce the addition of Dr. Ted Rygas as Technical Advisor, bringing extensive experience in uranium isotope enrichment, nuclear fuel-cycle technologies, separation science, chemical engineering, and advanced process development.</p> <p><strong>Dr. Rygas’ technical background includes:</strong></p> <ul type="disc"><li style="margin-bottom:4pt; text-align:justify;">Over 30 years of experience in separation science, isotope separation, process development, and pilot-plant operations</li><li style="margin-bottom:4pt; text-align:justify;">Former Research Engineer with Cameco Corporation, contributing to the CRISLA laser-based uranium isotope enrichment project</li><li style="margin-bottom:4pt; text-align:justify;">Independent consultant since 2017, http://www.streetinsider.com/Globe+Newswire/Purecore+Strengthens+Technical+Advisory+Expertise+with+Nuclear+Fuel+Cycle+and+Uranium+Enrichment+Specialist%2C+Ted+Rygas%2C+PhD/26645258.html Mon, 15 Jun 2026 09:30:00 -0400 A.04592075 A.04618790 A.08119513 J8Y O.00786429 O.01104272 O.02567468 PURE http://www.streetinsider.com/Globe+Newswire/Purecore+Strengthens+Technical+Advisory+Expertise+with+Nuclear+Fuel+Cycle+and+Uranium+Enrichment+Specialist%2C+Ted+Rygas%2C+PhD/26645258.html <p align="justify">VANCOUVER, British Columbia, June 15, 2026 (GLOBE NEWSWIRE) -- <strong>Purecore Metals Inc. (CSE: PURE) (FSE: J8Y) (“Purecore” or the “Company”)</strong> is pleased to announce the addition of Dr. Ted Rygas as Technical Advisor, bringing extensive experience in uranium isotope enrichment, nuclear fuel-cycle technologies, separation science, chemical engineering, and advanced process development.</p> <p><strong>Dr. Rygas’ technical background includes:</strong></p> <ul type="disc"><li style="margin-bottom:4pt; text-align:justify;">Over 30 years of experience in separation science, isotope separation, process development, and pilot-plant operations</li><li style="margin-bottom:4pt; text-align:justify;">Former Research Engineer with Cameco Corporation, contributing to the CRISLA laser-based uranium isotope enrichment project</li><li style="margin-bottom:4pt; text-align:justify;">Independent consultant since 2017, http://www.streetinsider.com/Globe+Newswire/Purecore+Strengthens+Technical+Advisory+Expertise+with+Nuclear+Fuel+Cycle+and+Uranium+Enrichment+Specialist%2C+Ted+Rygas%2C+PhD/26645258.html Mon, 15 Jun 2026 09:30:00 -0400 A.04592075 A.04618790 A.08119513 J8Y O.00786429 O.01104272 O.02567468 PURE http://www.streetinsider.com/Globe+Newswire/Purecore+Strengthens+Technical+Advisory+Expertise+with+Nuclear+Fuel+Cycle+and+Uranium+Enrichment+Specialist%2C+Ted+Rygas%2C+PhD/26645258.html <p align="justify">VANCOUVER, British Columbia, June 15, 2026 (GLOBE NEWSWIRE) -- <strong>Purecore Metals Inc. (CSE: PURE) (FSE: J8Y) (“Purecore” or the “Company”)</strong> is pleased to announce the addition of Dr. Ted Rygas as Technical Advisor, bringing extensive experience in uranium isotope enrichment, nuclear fuel-cycle technologies, separation science, chemical engineering, and advanced process development.</p> <p><strong>Dr. Rygas’ technical background includes:</strong></p> <ul type="disc"><li style="margin-bottom:4pt; text-align:justify;">Over 30 years of experience in separation science, isotope separation, process development, and pilot-plant operations</li><li style="margin-bottom:4pt; text-align:justify;">Former Research Engineer with Cameco Corporation, contributing to the CRISLA laser-based uranium isotope enrichment project</li><li style="margin-bottom:4pt; text-align:justify;">Independent consultant since 2017, http://www.streetinsider.com/Globe+Newswire/Purecore+Strengthens+Technical+Advisory+Expertise+with+Nuclear+Fuel+Cycle+and+Uranium+Enrichment+Specialist%2C+Ted+Rygas%2C+PhD/26645258.html Mon, 15 Jun 2026 09:30:00 -0400 A.04592075 A.04618790 A.08119513 J8Y O.00786429 O.01104272 O.02567468 PURE http://www.streetinsider.com/Press+Releases/Purecore+Announces+Listing+on+the+Frankfurt+Stock+Exchange/26603569.html <p align="justify">VANCOUVER, British Columbia, June 04, 2026 (GLOBE NEWSWIRE) -- <strong>Purecore Metals Inc. (CSE: PURE) (FSE: J8Y) (“Purecore” or the “Company”)</strong> is pleased to announce that its common shares are now listed for trading on the Frankfurt Stock Exchange under the symbol “J8Y”. The ISIN number for the common shares is CA7459371026 and the classification number (“WKN”) is A42ABN. The Company’s common shares will continue to trade on the Canadian Securities Exchange (“CSE”) under the symbol “PURE”.</p> <p align="justify">The Frankfurt Stock Exchange is one of the world’s largest securities trading centres and Germany’s leading stock exchange. Operated http://www.streetinsider.com/Press+Releases/Purecore+Announces+Listing+on+the+Frankfurt+Stock+Exchange/26603569.html Thu, 04 Jun 2026 09:30:00 -0400 J8Y PURE